Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Shafran

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 28, 2007
Management of chronic hepatitis B: consensus guidelinesMorris Sherman, Stephen Shafran, Kelly Burak, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 28, 2007
Management of chronic hepatitis C: consensus guidelinesMorris Sherman, Stephen Shafran, Kelly Burak, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
Journal of Viral Hepatitis|January 22, 2019
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment studyPeter Ruane, Simone I Strasser, Edward J Gane, et al.
Antiviral Therapy|June 27, 2017
Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvirDavid Wyles, Alessandra Mangia, Wendy Cheng, et al.
Gastroenterology|October 11, 2016
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Kwo, Edward J Gane, Cheng-Yuan Peng, et al.
World Journal of Gastroenterology|March 30, 2016
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 29, 2017
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxisDarrell H S Tan, Mark W Hull, Deborah Yoong, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 28, 2007
Management of chronic hepatitis B: consensus guidelinesMorris Sherman, Stephen Shafran, Kelly Burak, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 28, 2007
Management of chronic hepatitis C: consensus guidelinesMorris Sherman, Stephen Shafran, Kelly Burak, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
Journal of Viral Hepatitis|January 22, 2019
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment studyPeter Ruane, Simone I Strasser, Edward J Gane, et al.
Antiviral Therapy|June 27, 2017
Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvirDavid Wyles, Alessandra Mangia, Wendy Cheng, et al.
Gastroenterology|October 11, 2016
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Kwo, Edward J Gane, Cheng-Yuan Peng, et al.
World Journal of Gastroenterology|March 30, 2016
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 29, 2017
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxisDarrell H S Tan, Mark W Hull, Deborah Yoong, et al.
Pageof 2